<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Fidelity Convertible Securities Fund Fidelity Advisor Convertible Securities Fund: Class T — News on 6ix</title>
    <link>https://6ix.com/company/fidelity-convertible-securities-fund-fidelity-advisor-convertible-securities-fund-class-t</link>
    <description>Latest news and press releases for Fidelity Convertible Securities Fund Fidelity Advisor Convertible Securities Fund: Class T on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 22 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/fidelity-convertible-securities-fund-fidelity-advisor-convertible-securities-fund-class-t" rel="self" type="application/rss+xml" />
    <item>
      <title>ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint</title>
      <link>https://6ix.com/company/fidelity-convertible-securities-fund-fidelity-advisor-convertible-securities-fund-class-t/news/clearpoint-neuro-announces-fda-clearance-of-the-velocity-alphar-mr-high-speed-surgical-drill-system-and-first-clinical-use-further-expanding-our-drug-delivery-ecosystem-and-global-footprint-29</link>
      <guid isPermaLink="true">https://6ix.com/company/fidelity-convertible-securities-fund-fidelity-advisor-convertible-securities-fund-class-t/news/clearpoint-neuro-announces-fda-clearance-of-the-velocity-alphar-mr-high-speed-surgical-drill-system-and-first-clinical-use-further-expanding-our-drug-delivery-ecosystem-and-global-footprint-29</guid>
      <pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
      <description>SOLANA BEACH, CA / ACCESS Newswire / April 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (&quot;Company&quot;), a global device, cell, and gene therapy-enabling</description>
    </item>
    <item>
      <title>Marvell Announces Acquisition of Polariton Technologies, Advancing Optical Performance Scaling to 3.2T and Beyond</title>
      <link>https://6ix.com/company/fidelity-convertible-securities-fund-fidelity-advisor-convertible-securities-fund-class-t/news/marvell-announces-acquisition-of-polariton-technologies-advancing-optical-performance-scaling-to-32t-and-beyond-6</link>
      <guid isPermaLink="true">https://6ix.com/company/fidelity-convertible-securities-fund-fidelity-advisor-convertible-securities-fund-class-t/news/marvell-announces-acquisition-of-polariton-technologies-advancing-optical-performance-scaling-to-32t-and-beyond-6</guid>
      <pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
      <description>Adds Plasmonics-based Modulation Technology and a Team with Deep Silicon Photonics Expertise to Advance Marvell’s Optical Roadmap SANTA CLARA,</description>
    </item>
    <item>
      <title>EastGroup Properties Announces First Quarter 2026 Results</title>
      <link>https://6ix.com/company/fidelity-convertible-securities-fund-fidelity-advisor-convertible-securities-fund-class-t/news/eastgroup-properties-announces-first-quarter-2026-results-2</link>
      <guid isPermaLink="true">https://6ix.com/company/fidelity-convertible-securities-fund-fidelity-advisor-convertible-securities-fund-class-t/news/eastgroup-properties-announces-first-quarter-2026-results-2</guid>
      <pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
      <description>Quarter HighlightsNet Income Attributable to Common Stockholders of $1.77 Per Diluted Share for First Quarter 2026 Compared to $1.14 Per Diluted Share for</description>
    </item>
  </channel>
</rss>